UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
September 11, 2025
Accession Number:
0001641172-25-026154
Submission Type:
POS AM
CIK:
0001130166
Company Name:
Cyclacel Pharmaceuticals, Inc.
File Number:
333-286754